Characterization of proviral DNA from an individual with long-term, nonprogressive infection with HIV-1 and nonrecoverable virus

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 15, Issue 4, 1997, Pages 247-256

  Fujii, Shin Ichiro ^a   Obaru, Kenshi ^a   Matsushita, Shuzo ^a   Morikita, Tatsuma ^a   Higuchi, Hirofumi ^b   Fujimoto, Koji ^a   Takatsuki, Kiyoshi ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b Chemo Sero Therapeutic Research Institute   (Japan)

Author keywords

Long PCR; Long term nonprogressor (LTNP); Vaccine

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CASE REPORT; DNA DETERMINATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERMINAL REPEAT; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS CHARACTERIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030764059     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199708010-00001     Document Type: Article

References (60)

1. Lifson AR, Rutherford GW, Jaffe HW. The natural history of human immunodeficiency virus infection. J Infect Dis 1988;158: 1360-7.
2. Jason J, Lui K-J, Ragni MV, Hessol NA, Darrow WW. Risk of developing AIDS in HIV-infected cohorts of hemophiliac and homosexual men. JAMA 1989;261:725-7.
3. Rutherford GW, Lifson AR, Hessol NA. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. Br Med J 1990;301:1183-8.
4. Schrager LK, Young JM, Fowler MG, Mathieson BJ, Vermund SH. Long-term survivors of HIV-1 infection: definitions and research challenges. AIDS 1994;8:S95-S108.
5. Buchbinder SP, Katz MH, Hessol NA, O'Malle PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS 1994;8:1123-8.
6. + cell counts. J Infect Dis 1994; 169:1236-43.
7. + T-cell levels. AIDS 1993;7:1159-66.
8. Learmont J, Cook L, Dunckley H, Sullivan JS. Update on long-term symptomless HIV type 1 infection in recipients of blood products from a single donor. AIDS Res Hum Retroviruses 1995; 11:1.
9. Greenough TC, Somasundaran M, Brettler DB, et al. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1994;10:395-403.
10. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16.
11. Cao Y, Qin L, Zhang L, Safrit J, Ho DD. Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
12. Koup RA, Sullivan JL, Levine PH, et al. Detection of major histocompatibility complex class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 1989; 73:1909-14.
13. Koup RA, Pikora CA, Luzuriaga K, et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 1991; 174:1593-600.
14. + cell anti-HIV activity correlates with the clinical state of the infected individual. J Clin Invest 1991;87:1462-6.
15. Klein MR, van Baalen CA, Holwerda AM, et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J Exp Med 1995;181: 1365-72.
16. Haynes BF, Pantaleo G, Fauci AS. Toward an understanding of the correlates of protective immunity to HIV infection. Science 1996; 271:324-8.
17. Connor RI, Ho DD. Transmission and pathogenesis of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 1994; 10:321-3.
18. + T cells. Science 1995;270:1811-5.
19. Williams LM, Cloyd MW. Polymorphic human gene(s) determines differential susceptibility of CD4 lymphocytes to infection by certain HIV-1 isolates. Virology 1991;184:723-8.
20. Roos MTL, Lange JMA, De Goede REY, et al. Viral phenotype and immune response in primary human immunodeficiency virus type 1 infection. J Infect Dis 1992;165:427-32.
21. + lymphocytes of seropositive individuals. J Infect Dis 1991;164:470-5.
22. Yerly S, Chamot E, Hischel B, Perrin LH. Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters. J Infect Dis 1992;166:269-76.
23. Kirchhoff F, Kestler HW III, Desrosiers RC. Upstream U3 sequences in simian immunodeficiency virus are selectively deleted in vivo in the absence of an intact nef gene. J Virol 1994;68: 2031-7.
24. Adams M, Sharmeen L, Kimpton J, et al. Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc Natl Acad Sci USA 1994;91:3862-6.
25. Rump JA, Peter HH, Schneider J, Haller O. Long-term survivors with continuously high levels of HIV type 1. AIDS Res Hum Retroviruses 1996;12:757-8.
26. Jurriaans S, van Germen B, Weverling GJ, et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology 1994;204:223-33.
27. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. N Engl J Med 1995;332:228-32.
28. Deacon NJ, Tsykin A, Solomon A, et al. Genomic structure of an attenuated quasispecies of HIV-1 from a blood transfusion donor and recipients. Science 1995;270:988-91.
29. Learmont J, Tindall B, Evans L, et al. Long-term symptomless HIV-1 infection in recipients of blood products from a single donor. Lancet 1992;340:863-7.
30. Cannon P, Kim SH, Ulich C, Kim S. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2. J Virol 1994;68:1993-7.
31. Duan L, Oakes JW, Ferraro A, Bagasra O, Pomerantz RJ. Tat and Rev differentially affect restricted replication of human immunodeficiency virus type 1 in various cells. Virology 1994;199:474-8.
32. Michael NL, D'arcy L, Ehrenberg PK, Redfield RR. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities. J Virol 1994;68:3163-74.
33. Michael NL, Vahey M, Burke DS, Redfield RR. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J Virol 1992;66:310-6.
34. Simmonds P, Balfe P, Peutherer JF, Ludlam CA, Bishop JO, Brown AJL. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J Virol 1990;64:864-72.
35. Pomerantz RJ, Trono D, Feinberg M, Baltimore D. Cells nonproductively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 1990;61: 1271-6.
36. Kim S, Bryn R, Groopman J, Baltimore D. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection. J Virol 1989;63:3708-23.
37. Bagasra O, Pomerantz RJ. Human immunodeficiency virus type 1 provirus is demonstrated in peripheral blood monocytes in vivo: a study utilizing an in situ polymerase chain reaction. AIDS Res Hum Retroviruses 1993;9:69-76.
38. Patterson BK, Till M, Otto P, et al. Detection of HIV-1 DNA and messenger RNA in individual cells by PCR-driven in situ hybridization and flow cytometry. Science 1993;260:976-9.
39. Cheng S, Fockler C, Barnes WM, Higuchi R. Effective amplification of long targets from cloned inserts and human genomic DNA. Proc Natl Acad Sci USA 1994;91:5695-9.
40. Cheng S, Chang SY, Gravitt P, Respess R. Long PCR. Nature 1994;369:684-5.
41. Barnes WM. PCR amplification of up to 35-kb DNA with high fidelity and high yield from λ bacteriophage templates. Proc Natl Acad Sci USA 1994;91:2216-20.
42. Mulder J, McKinney N, Christopherson C, Sninsky J, Greenfield L, Kwok S. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J Clin Microbiol 1994;32:292-300.
43. Vicenzi E, Bagnarelli P, Santagostino E, et al. Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood 1997;89:191-200.
44. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-31.
45. Aoki S, Yarchoan R, Thomas RV, et al. Quantitative analysis of HIV-1 proviral DNA in peripheral blood mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2′, 3′-dideoxyinosine (ddI). AIDS Res Hum Retroviruses 1990;6:1331-9.
46. Ho DD, Moudgil T, Alam M. Quantitation of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989;321:1621-5.
47. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324:961-4.
48. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J Virol 1993;67:1772-7.
49. + lymphocyte counts: immunologic and virologie characteristics. J Infect Dis 1991;163:959-65.
50. Greenough T, Blais B, Byron K, Brettler D, Sullivan JL. Quantitation of HIV-1 specific cytotoxic T-lymphocytes and correlation with viral load (abstract). Clin Res 1992;40:355A.
51. Daniel MD, Kirchhoff F, Czajak SC, Sehgal PK, Desrosiers RC. Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene. Science 1992;258:1938-41.
52. Huang Y, Zhang L, Ho DD. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1995;69:93-100.
53. Connor RI, Scheridan KE, Lai C, et al. Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1996;70: 5306-11.
54. Desrosiers RC. HIV with multiple gene deletions as a live attenuated vaccine for AIDS. AIDS Res Hum Retroviruses 1992;8:411-21.
55. Baba TW, Jeong YS, Penninck D, Bronson R, Greene MF, Ruprecht RM. Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques. Science 1995;267:1820-5.
56. Cohen J. AIDS vaccines: is older better? Science 1992;258: 1880-1.
57. Cohen J. Can one type of HIV protect against another type? Science 1995;268:1566.
58. Bryson YJ, Pang S, Wei LS, Dickover R, Diagne A, Chen ISY. Clearance of HIV infection in a perinatally infected infant. N Engl J Med 1995;332:833-8.
59. Marlink R, Kanki P, Thior I, et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994; 265:1587-90.
60. Travers K, Mboup S, Marlink R, et al. Natural protection against HIV-1 infection provided by HIV-2. Science 1995;268:1612-5.